Matinas BioPharma
agreed phase study design in invasive aspergillosis the trial | Matinas BioPharma
Company
Deck Type
Sector
Industry
Deck date
March 2024
Slide
16 of 29
Similar slides by Matinas BioPharma
See diffirences between slides (animation)
Investor Presentation
February 2024
agreed phase study design in invasive aspergillosis the trial | Matinas BioPharma
Investor Presentation
January 2024
proposed phase study design in invasive aspergillosis | Matinas BioPharma
Investor Presentation
November 2023
proposed phase study design in invasive aspergillosis a i | Matinas BioPharma
Investor Presentation
August 2023
phase aspergillosis study preliminary design subject to agreement | Matinas BioPharma
Related slides by other companies
BioAtla
Investor Presentation
November 2022
phase study design with in refractory patients | BioAtla
Ocuphire Pharma
Investor Presentation
November 2021
presbyopia phase design | Ocuphire Pharma
Theravance Biopharma
Investor Conference
November 2022
study design | Theravance Biopharma
Ocuphire Pharma
Results
June 2021
presbyopia phase design | Ocuphire Pharma
Other recent decks by Matinas BioPharma
See all presentations (7 decks)
Investor Presentation
February 2024
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights